SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Share News (IDH)

  • There is currently no data for IDH

IDH.L News

Immunodiagnostic Systems gets emergency FDA approval for Covid-19 test
29 Mar 2021

Immunodiagnostic Systems gets emergency FDA approval for Covid-19 test

(Sharecast News) - Clinical laboratory diagnostic technology company Immunodiagnostic Systems (IDS) has reached an agreement with its partner Technoge...

Immunodiagnostic gets US emergency green light for Covid-19 virus test
29 Mar 2021

Immunodiagnostic gets US emergency green light for Covid-19 virus test

Immunodiagnostic gets US emergency green light for Covid-19 virus test

Immunodiagnostic Systems launces two rapid Covid-19 tests
27 Nov 2020

Immunodiagnostic Systems launces two rapid Covid-19 tests

(Sharecast News) - Clinical laboratory diagnostics company Immunodiagnostic Systems announced on Friday that two SARS-CoV-2 antigen rapid test kits fo...

UK WINNERS & LOSERS SUMMARY: Immunodiagnostic Up On Covid Kit Rollout
27 Nov 2020

UK WINNERS & LOSERS SUMMARY: Immunodiagnostic Up On Covid Kit Rollout

UK WINNERS & LOSERS SUMMARY: Immunodiagnostic Up On Covid Kit Rollout

Immunodiagnostic Systems Notes Rollout Of Covid-19 Rapid Test Kits
27 Nov 2020

Immunodiagnostic Systems Notes Rollout Of Covid-19 Rapid Test Kits

Immunodiagnostic Systems Notes Rollout Of Covid-19 Rapid Test Kits

IN BRIEF: Immunodiagnostic Systems Interim Loss Widens On Revenue Drop
20 Nov 2020

IN BRIEF: Immunodiagnostic Systems Interim Loss Widens On Revenue Drop

IN BRIEF: Immunodiagnostic Systems Interim Loss Widens On Revenue Drop

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma Hires Blake Hughes As New CEO
18 Nov 2020

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma Hires Blake Hughes As New CEO

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma Hires Blake Hughes As New CEO

IN BRIEF: Immunodiagnostic Systems Interim Revenue Falls By 21%
23 Oct 2020

IN BRIEF: Immunodiagnostic Systems Interim Revenue Falls By 21%

IN BRIEF: Immunodiagnostic Systems Interim Revenue Falls By 21%